Clinical Trials Browser

INDUSTRY × HuMax-IL8 × Clear all

NCT03400332 2026-02-24

A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers

Phase 1/2 Completed

281 enrolled 44 charts

Melanoma, Neoplasms

NCT02536469 2017-02-03

HuMax-IL8 (Interleukin8) in Patients With Advanced Malignant Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor